Federation des caisses Desjardins du Quebec’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-500	Closed	-$328	–	2787
2024 Q4	$328	Hold	500	–	–	﹤0.01%	2426
2024 Q3	$189	Hold	500	–	–	﹤0.01%	2459
2024 Q2	$635	Hold	500	–	–	﹤0.01%	2234
2024 Q1	$945	Hold	500	–	–	﹤0.01%	2198
2023 Q4	$1.38K	Buy	+500	New	+$1.61K	﹤0.01%	2117

Other funds holding NKGN

Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

UOC

University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's NKGN Position: Q1 2025 in Review

Federation des caisses Desjardins du Quebec sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q1 2025, closing a stake of 500 shares — an estimated $328 sold.

Federation des caisses Desjardins du Quebec first reported a position in NKGN in Q4 2023 and held it in 5 quarters. The position peaked at $1.38K in Q4 2023. 3 funds tracked by Wall St. Rank hold NKGN as of Q1 2025.

Federation des caisses Desjardins du Quebec reported no remaining NKGen Biotech, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 500 NKGen Biotech, Inc. Common Stock shares in Q1 2025, an estimated $328.
Federation des caisses Desjardins du Quebec first reported a position in NKGen Biotech, Inc. Common Stock in Q4 2023 and held it in 5 quarters.
Federation des caisses Desjardins du Quebec's NKGen Biotech, Inc. Common Stock position peaked at $1.38K in Q4 2023.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q1 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2025, filed 15 May 2025.